Table 2.
Mean ± SEM of FBG, FIns, BW and Lee index in the stages pre and post induction of type 2 diabetes.
| Group | Pre HFD | Post HFD | Post HFD/STZ | Post protocol | |
|---|---|---|---|---|---|
| FBG (mmol/L) |
H-C | 6.71 ± .205 | 6.70 ± .154 | 6.96 ± .181 | 6.78 ± .314 |
| D-C | 6.83 ± .237 | 11.73 ± .231 | 21.76 ± .351 | 22.98 ± .155 | |
| D-RT | 6.55 ± .222 | 12.63 ± .236 | 22.94 ± .124 | 18.09 ± .197 | |
| D-Ha | 6.56 ± .198 | 12.41 ± .250 | 22.18 ± .407 | 17.96 ± .379 | |
| D-RT-Ha |
6.74 ± .243 |
12.04 ± .364 |
22.21 ± .464 |
15.43 ± .778 |
|
| FIns (μU/ml) |
H-C | 10.44 ± .282 | 10.62 ± .449 | 10.36 ± .335 | 10.25 ± .282 |
| D-C | 10.61 ± .355 | 13.94 ± .407 | 7.35 ± .138 | 4.98 ± .122 | |
| D-RT | 11.01 ± .266 | 13.85 ± .757 | 6.74 ± .345 | 7.80 ± .252 | |
| D-Ha | 10.76 ± .332 | 14.74 ± .791 | 6.65 ± .230 | 7.67 ± .360 | |
| D-RT-Ha |
10.86 ± .223 |
14.10 ± .631 |
7.19 ± .169 |
9.85 ± .615 |
|
| BW (gr) |
H-C | 185.27 ± 2.12 | 215.50 ± 1.70 | 216.50 ± 1.70 | 268.37 ± 2.35 |
| D-C | 188.30 ± 1.67 | 349.50 ± 1.19 | 344.25 ± 1.49 | 332 ± 2.85 | |
| D-RT | 186.62 ± 2.56 | 348 ± 1.29 | 343.25 ± 1.49 | 339 ± .577 | |
| D-Ha | 185.82 ± 2.63 | 347 ± 1.91 | 342.25 ± 1.10 | 339 ± .707 | |
| D-RT-Ha |
187.40 ± 2.69 |
349.75 ± .946 |
344.75 ± 1.03 |
324.25 ± 3.32 |
|
| Lee Index | H-C | .029 ± .001 | .027 ± .001 | .027 ± .001 | .026 ± .001 |
| D-C | .029 ± .000 | .032 ± .000 | .031 ± .000 | .029 ± .000 | |
| D-RT | .0291 ± .000 | .031 ± .000 | .030 ± .000 | .029 ± .000 | |
| D-Ha | .029 ± .001 | .031 ± .001 | .031 ± .001 | .029 ± .000 | |
| D-RT-Ha | .029 ± .000 | .031 ± .000 | .031 ± .000 | .028 ± .000 |